December 1, 2003
United Press International
New York University scientists have developed a way to measure the severity of a patient's multiple sclerosis and gauge how well drugs are working.
The researchers report the new technique will improve both diagnosis and treatment of the disease. The technique measures the amount of a key chemical found in lower quantities than usual in the brain cells of MS patients.
"MS is a progressive brain disorder that leads to having less and less of the chemical in the brain," lead researcher, Professor Oded Gonen, told the BBC. "The deficit is proportional to the severity of the disease, as is the rate of the loss of the chemical."
Details were revealed at a recent Radiological Society of North America meeting.
Precise and early diagnosis will enable physicians to adapt therapy
to suit the individual and possibly slow down the progression of the MS.
Copyright © 2003, United Press International